United States · FDA National Drug Code directory
budesonide inhalation
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68180-984_3315e8ee-f729-4dab-86e4-349ab1c9c9ca
- Product NDC
- 68180-984
- Form
- SUSPENSION
- Composition / generic term
- budesonide inhalation
- Labeler
- Lupin Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190521
- Source listing expiry
- 20261231
Source-listed ingredients
- BUDESONIDE — .5 mg/2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 6 POUCH in 1 CARTON (68180-984-30) / 5 AMPULE in 1 POUCH / 2 mL in 1 AMPULE · 68180-984-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →